NCT07409077 Efficacy of Biofeedback Training for Glaucoma
| NCT ID | NCT07409077 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Glaucoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2028-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-02-10 with a primary completion date of 2028-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled clinical trial evaluates the efficacy of visual biofeedback training on visual function and quality of life in individuals with glaucoma. Glaucoma is a progressive optic neuropathy that can lead to irreversible vision loss, including impaired fixation stability, reduced retinal sensitivity, and decreased functional vision. Biofeedback training is a visual rehabilitation technique designed to help patients improve fixation stability and optimize use of remaining visual function by training eye movements toward retinal areas with better sensitivity. Seventy participants with glaucoma will be randomized to either a biofeedback training intervention group or a control group. Visual function outcomes, including fixation stability, retinal sensitivity, visual acuity, reading speed, contrast sensitivity, and quality of life, will be assessed at baseline and follow-up visits. This study aims to determine whether biofeedback training can improve visual function and quality of life in patients with glaucoma.
Eligibility Criteria
Inclusion Criteria: * 18-95 years old. * Glaucoma cases with adequate intraocular pressure control. * Presence of paracentral scotomata within two degrees of fixation. * Ability to follow instructions for biofeedback training. Exclusion Criteria: * Prior or current low vision rehabilitation treatment. * Ocular diseases or severe clinical conditions unrelated to glaucoma * Media opacities that prevent reliable microperimetry testing in both eyes. * Inability to perform study assessments or follow instructions for biofeedback training.
Frequently Asked Questions
Who can join the NCT07409077 clinical trial?
This trial is open to participants of all sexes, studying Glaucoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07409077 currently recruiting?
Yes, NCT07409077 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Health Network, Toronto to inquire about joining.
Where is the NCT07409077 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07409077 clinical trial?
NCT07409077 is sponsored by University Health Network, Toronto. The trial plans to enroll 70 participants.